Editas Medicine, Inc. (EDIT): Shares Outstanding

Annual figures by period end, from SEC filings.

97.87M
As of 2025-12-31
97.87M
As of 2026-06-30
+12.4%
3-year compound annual growth
+9.4%
5-year compound annual growth
+40.6%
10-year compound annual growth
2015-12-31: 3.23M2016-12-31: 35.82M2017-12-31: 44.51M2018-12-31: 48.76M2019-12-31: 54.36M2020-12-31: 62.56M2021-12-31: 68.44M2022-12-31: 68.85M2023-12-31: 81.77M2024-12-31: 82.73M2025-12-31: 97.87M97.87M
2015-12-31 Shares Outstanding (shares) 2025-12-31
Period endedShares OutstandingChange YoYSource filing
2025-12-3197.87M+18.3%2026-03-09, Balance as of period end
2024-12-3182.73M+1.2%2026-03-09, Balance as of period end
2023-12-3181.77M+18.8%2025-03-05, Balance as of period end
2022-12-3168.85M+0.6%2024-02-28, Balance as of period end
2021-12-3168.44M+9.4%2023-02-22, Balance as of period end
2020-12-3162.56M+15.1%2022-02-24, Balance as of period end
2019-12-3154.36M+11.5%2021-02-26, Balance as of period end
2018-12-3148.76M+9.6%2020-02-26, Balance as of period end
2017-12-3144.51M+24.3%2019-03-01, Balance as of period end
2016-12-3135.82Mn/m2018-03-08, Balance as of period end
2015-12-313.23Mn/a2017-03-03, Balance as of period end